Over the four-year period, the percentage of female patients with a semaglutide or tirzepatide prescription who also had PCOS increased from 4.6% in 2021 to 5.7% in 2025, representing a 23.9% relative increase
Clinically, qualifying for GLP-1 therapy typically requires meeting one of two conditions: a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater combined with an obesity-related comorbidity such as type 2 diabetes or cardiovascular risk factors
How We Evaluated This review was conducted using publicly available information and does not represent a clinical evaluation, endorsement, or recommendation
Medical supervision ensures proper dosing, lab monitoring, and adjustments based on your bodys unique response
A Comprehensive Medical Evaluation At LIFE Pediatric Endocrinology, every child begins with a comprehensive physician evaluation designed to identify the factors contributing to weight gain
Melatonin is one of the most popular sleep supplements in the world